The FKTN Gene Walker-Warburg Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the FKTN gene, which are known to cause Walker-Warburg Syndrome (WWS). WWS is a rare genetic disorder characterized by severe brain malformations, muscle weakness, and eye abnormalities. Early and accurate diagnosis through this genetic test allows for better understanding of the condition, guiding treatment and management decisions for affected individuals.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw, and analyzing the genetic material for specific mutations in the FKTN gene. This gene plays a crucial role in the development and maintenance of muscle and brain tissue, and mutations can lead to the symptoms associated with WWS.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the FKTN Gene Walker-Warburg Syndrome Genetic Test provides families with critical information regarding the genetic makeup and potential health challenges their loved ones may face, enabling informed healthcare decisions and support for managing the condition.
The FKRP gene (Fukutin-Related Protein gene) plays a critical role in the proper development and maintenance of muscle tissue, the brain, and the eyes. Mutations in the FKRP gene can lead to severe congenital disorders such as Walker-Warburg Syndrome (WWS) and Muscle-Eye-Brain (MEB) Disease. These conditions are characterized by muscle weakness, structural brain defects, and eye abnormalities. They are part of a group of diseases known as congenital muscular dystrophies.
To diagnose these conditions and understand the genetic basis in affected individuals, genetic testing focusing on the FKRP gene is essential. DNA Labs UAE offers a comprehensive FKRP Related Genetic Test, which is a vital tool in diagnosing conditions like Walker-Warburg Syndrome or Muscle-Eye-Brain Disease. This test is particularly crucial for families with a history of these disorders, as it can provide valuable information for disease management and genetic counseling.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities. The cost of the FKRP Related Genetic Test is 4400 AED. This investment can be invaluable for affected families, offering insights into the genetic mutations responsible for these conditions and facilitating informed decisions regarding care and treatment.
The RAB3GAP1 gene is essential in the regulation of a process known as membrane trafficking within cells. Mutations in this gene are primarily associated with Warburg Micro Syndrome Type 1, a rare genetic disorder characterized by a range of symptoms including developmental delays, microcephaly, eye abnormalities, and hypotonia. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose this syndrome and identify the specific genetic mutation, a genetic test targeting the RAB3GAP1 gene can be conducted. This test is crucial for families seeking a definitive diagnosis, understanding the risk of recurrence in future pregnancies, and accessing appropriate care and support for affected individuals.
DNA Labs UAE offers this specialized genetic test for Warburg Micro Syndrome Type 1. The test involves analyzing the patient's DNA to detect mutations in the RAB3GAP1 gene that are indicative of the syndrome. This process provides a precise diagnosis, enabling targeted management and care for the affected individual.
The cost of the RAB3GAP1 Gene Warburg Micro Syndrome Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full analysis and reporting, offering families valuable insights into their genetic makeup and aiding in the management of the condition. It's important for interested individuals to consult with healthcare professionals and genetic counselors to understand the implications of the test results fully.
The "TWNK Gene Spinocerebellar Ataxia Infantile-Onset Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the TWNK gene, which are associated with the development of spinocerebellar ataxia with infantile onset. Spinocerebellar ataxia is a progressive, degenerative genetic disorder characterized by poor coordination of hands, eyes, and speech, as well as a loss of motor control that typically begins in childhood. The TWNK gene plays a crucial role in mitochondrial DNA replication and maintenance; mutations in this gene can disrupt these processes, leading to the symptoms observed in affected individuals.
This genetic test is critical for early detection and management of the condition, enabling healthcare providers to offer targeted interventions that can improve the quality of life for affected individuals. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the TWNK gene.
The cost of the "TWNK Gene Spinocerebellar Ataxia Infantile-Onset Genetic Test" at DNA Labs UAE is 4400 AED. This investment covers the expenses related to the sophisticated techniques and equipment required for accurate genetic analysis. Early and precise diagnosis through this test can be instrumental in guiding treatment decisions, providing genetic counseling, and facilitating family planning for those carrying the gene mutation.
The "SHROOM4 Gene Stocco dos Santos X-Linked Mental Retardation Syndrome Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the SHROOM4 gene, which are linked to Stocco dos Santos Syndrome. This rare genetic disorder is characterized by intellectual disability, seizures, and other neurological issues, and it predominantly affects males due to its X-linked inheritance pattern. The test involves analyzing the patient's DNA to detect any abnormalities in the SHROOM4 gene that could lead to the syndrome. With a cost of 4400 AED, this test is a critical tool for families seeking answers about this specific genetic condition, enabling early intervention and management strategies to improve the quality of life for affected individuals.
The PDE8B Gene Striatal Degeneration Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the PDE8B gene, which have been associated with striatal degeneration. Striatal degeneration is a neurological condition characterized by the progressive deterioration of the striatum, a critical part of the brain involved in motor control and various cognitive processes. Mutations in the PDE8B gene can lead to disrupted signaling pathways within the brain, contributing to the development of this condition.
This genetic test is crucial for individuals who exhibit symptoms of striatal degeneration or have a family history of the disease, as early detection can aid in the management and treatment of symptoms. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the PDE8B gene.
The cost of the PDE8B Gene Striatal Degeneration Genetic Test at DNA Labs UAE is 4400 AED. This price includes the comprehensive analysis and a detailed report of the findings, which can provide valuable insights for healthcare providers in developing a personalized treatment plan for affected individuals. Given the complexity and the specialized nature of this test, it represents a significant step forward in the field of genetic diagnostics and personalized medicine, offering hope to those affected by striatal degeneration and their families.
The SLC25A19 Gene Thiamine Metabolism Dysfunction Syndrome 4 Progressive Polyneuropathy Type Genetic Test is a specialized diagnostic procedure designed to identify mutations in the SLC25A19 gene, which are associated with Thiamine Metabolism Dysfunction Syndrome 4 (also known as Progressive Polyneuropathy). This condition is a rare genetic disorder that affects the body's ability to metabolize thiamine properly, leading to a range of neurological symptoms including progressive polyneuropathy, characterized by the deterioration of nerve function.
The test is crucial for individuals displaying symptoms related to thiamine metabolism dysfunction, as early detection and management can significantly improve the quality of life. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to detect mutations in the SLC25A19 gene that are indicative of the syndrome.
The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. By providing a definitive diagnosis, this genetic test enables healthcare providers to tailor treatment and management plans specifically for the patient's condition, potentially including thiamine supplementation among other strategies.
Overall, the SLC25A19 Gene Thiamine Metabolism Dysfunction Syndrome 4 Progressive Polyneuropathy Type Genetic Test represents a vital tool in the diagnosis and management of this rare but impactful disorder, offering hope and direction for affected individuals and their families.
The CACNA1S gene plays a crucial role in the normal functioning of skeletal muscle cells. Mutations in this gene can lead to Thyrotoxic Periodic Paralysis Type 1, a condition characterized by episodes of muscle weakness or paralysis, often triggered by high levels of thyroid hormones. This genetic disorder is linked to an abnormal response of muscle cells to potassium levels in the body, particularly during instances of thyrotoxicosis, where excessive thyroid hormone is present.
To diagnose this condition and differentiate it from other forms of periodic paralysis, genetic testing of the CACNA1S gene is essential. DNA Labs UAE offers a comprehensive genetic test specifically designed to identify mutations in the CACNA1S gene associated with Thyrotoxic Periodic Paralysis Type 1. This test is pivotal for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding treatment decisions.
The cost of the CACNA1S Gene Thyrotoxic Periodic Paralysis Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis required to detect the presence of the specific genetic alterations within the CACNA1S gene that cause the disorder. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic basis of the symptoms, enabling personalized management plans that can significantly improve the quality of life for those affected by this condition.
The KCNJ18 gene plays a critical role in the development of Thyrotoxic Periodic Paralysis Type 2 (TPP2), a rare condition that manifests as episodes of muscle weakness in individuals with hyperthyroidism. The genetic test for TPP2 focuses on identifying mutations in the KCNJ18 gene, which can help in diagnosing the condition accurately and facilitating appropriate treatment strategies. Conducted at DNA Labs UAE, this genetic test is priced at 4400 AED. It is a crucial step for individuals exhibiting symptoms of TPP2 or those with a family history of the condition, offering them a clearer understanding of their genetic predisposition and guiding healthcare professionals in tailoring personalized management plans.
The ITPR1 gene is implicated in Spinocerebellar Ataxia Type 29 (SCA29), a rare, congenital, nonprogressive neurological disorder characterized by early-onset ataxia, delayed motor development, and mild cognitive impairment. This condition is inherited in an autosomal dominant pattern, meaning a mutation in just one copy of the gene in each cell is sufficient to cause the disorder. The ITPR1 gene plays a crucial role in calcium signaling within cells, essential for various cellular processes, including coordination and motor control, which are affected in SCA29.
To diagnose SCA29 and confirm its genetic basis, a specific genetic test is available at DNA Labs UAE. This test focuses on identifying mutations in the ITPR1 gene that are responsible for the condition. Given the complexity of genetic testing and the need for precise results, the test is priced at 4400 AED. Conducting this test can provide crucial information for families affected by SCA29, enabling them to understand the genetic underpinnings of the disorder, consider genetic counseling, and make informed decisions regarding management and support for affected family members.
